| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Riedel Norbert G serves as a Director at ETON and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 1 buy and 12 sells. Those positions are worth an estimated $2.0M at current prices.
Historically, Riedel Norbert G's trades have earned a middling insider score of 63/100 across 4 rated trades. Over a 12-month horizon, 75.0% of those trades were profitable, with an average 12-month return of +11.8%.
The biggest single holding is JAZZ (~$1.7M) as Director. The recent filings there lean toward selling, a net 19,307 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 16, 2016 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 644 | $145.20 | $93,508.80 | -13.2% |